Multidrug transporters P-GP, MRP1, and ABCG2 in chemoresistant breast and colorectal cancer cells—who takes the lead?
Journal of Advanced Biotechnology and Experimental Therapeutics · 2026 · 9 (1) · 1
DOI: 10.5455/jabet.2026.01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advanced Biotechnology and Experimental Therapeutics, 2026. Verfasst von Sudipta Nath und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Despite significant advances in the discovery and efficacy of anticancer drugs, chemoresistance remains a major issue in cancer treatment and management. Hyperactivity of efflux pumps is one of the key mechanisms through which cancer cells acquire chemoresistance. This study investigates the expression patterns of P-GP, MRP1, and ABCG2 in 49 paired chemoresistant breast and colorectal cancer tissues using immunofluorescence imaging and statistical applications. Among breast cancer patients, 92.86% were diagnosed with infiltrating ductal carcinoma, whereas in the case of colorectal cancer, 100% had adenocarcinoma. Our immunofluorescence data show concurrent expression of ABCG2, MRP1, and P-GP across all chemoresistant breast and colorectal cases, suggesting a synergistic action of these transporters in developing chemoresistance, although the expression level varied for the transporters. Expression of ABCG2 exceeded P-GP and MRP1 expression in most cases. We suggest that a combinative and targeted therapeutic approach may be beneficial to improve the prognosis of cases with chemoresistance.
Zitieren
APA
Nath, S., Akash, M., Tanim, M., Akhteruzzaman, S., Mostafa, M., & Sajib, A. (2026). Multidrug transporters P-GP, MRP1, and ABCG2 in chemoresistant breast and colorectal cancer cells—who takes the lead?. Journal of Advanced Biotechnology and Experimental Therapeutics, 9(1), 1. https://doi.org/10.5455/jabet.2026.01
Vancouver
Nath S, Akash M, Tanim M, Akhteruzzaman S, Mostafa M, Sajib A. Multidrug transporters P-GP, MRP1, and ABCG2 in chemoresistant breast and colorectal cancer cells—who takes the lead?. Journal of Advanced Biotechnology and Experimental Therapeutics. 2026;9(1):1. doi:10.5455/jabet.2026.01
BibTeX
@article{Nath2026,
author = {Nath, Sudipta and Akash, Md. and Tanim, Md and Akhteruzzaman, Sharif and Mostafa, Mohammad and Sajib, Abu},
title = {Multidrug transporters P-GP, MRP1, and ABCG2 in chemoresistant breast and colorectal cancer cells—who takes the lead?},
journal = {Journal of Advanced Biotechnology and Experimental Therapeutics},
year = {2026},
volume = {9},
number = {1},
pages = {1},
doi = {10.5455/jabet.2026.01}
}
EUVIMED